Introduction
The kidneys were removed and sliced to a thickness of 1 mm. When estrogen-injected rats were used in some experiments, the procedure used before (1) was followed.
Immunologic titration--We prepared two kinds of supernatant fluids (20,000 x g, 10 min) , one from control animals and the other from estradiol-injected animals.
Different aliquots (0.0 1 -0.40 ml) of each supernatant fluid were taken to react with 10 ~1 of the anti-OAT serum or a control serum in the presence of 0.9% NaCl and brought to 1 ml with 0.0 1 M phosphate buffer, pH 7.4. After incubation at 4' for 24 hr, the tubes were centrifuged at 10,000 x g for 10 min.
Aliquots of the supernatant fluids were assayed for OAT activity. and washed with several ml of cold 0.9% NaCl. Each filter was then dissolved in 1 ml of 2-methoxyethanol in a counting vial, followed by 10 ml of a scintillation fluid (6.4 g PPO in 800 ml toluene and 200 ml 2-methoxyethanol) .
The counting was done in a Packard Tri-Carb Model 3310 with 85% efficiency.
Total proteins in the 20,000 x g -supernatant fluids from kidney slices were precipitated in 3.3% trichloroacetic acid, collected on microporous filters, and washed with the acid. The counts were determined as for the labeled OAT.
OAT activity assay--The enzyme activity was assayed according to Herzfeld and Knox (6), but with the concentration of a-ketoglutarate increased to 0.02 M in the assay medium.
One unit of activity is defined as the amount of enzyme that will cause the formation of 1 pmole of glutamate Y-semialdehyde per hr. Protein was determined by the procedure of Lowry et al. (7).
Results and Discussion
To determine whether estrogens induce OAT in rat kidney in vivo, we used 
